Get an alert when X-PHARM LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-12-31 (in 7mo)

Last filed for 2025-03-31

Confirmation statement due

2027-02-26 (in 9mo)

Last made up 2026-02-12

Watchouts

1 item

Cash

£1M

+3.5% vs 2024

Net assets

£795K

-51.5% vs 2024

Employees

209

-0.9% vs 2024

Profit before tax

£722K

-9.4% vs 2024

Watchouts

Facts from the Companies House register and the latest accounts — not a rating

Accounts

2-year trend · latest reflected 2025-03-31

Metric Trend 2024-03-312025-03-31
Turnover £27,507,528£28,376,355
Operating profit £1,546,333£1,538,812
Profit before tax £797,499£722,152
Net profit £681,556-£21,616
Cash £1,391,889£1,441,052
Total assets less current liabilities £9,239,001£7,707,386
Net assets £1,641,707£795,418
Equity £1,641,707£795,418
Average employees 211209
Wages £4,321,005£4,341,844
Directors' remuneration £43,502£47,661

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Year-on-year

FY2024 → FY2025 · period ending 2025-03-31 vs 2024-03-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2024-03-312025-03-31
Operating margin 5.6%5.4%
Net margin 2.5%-0.1%
Return on capital employed 16.7%20.0%
Gearing (liabilities / total assets) 82.2%89.7%
Current ratio 1.56x1.57x
Interest cover 1.93x1.75x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
Xeinadin Audit Limited
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.”

Group structure

  1. X-PHARM LIMITED · parent
    1. Wallgreen Limited 100% · England and Wales
    2. Ramdev Limited 100% · England and Wales
    3. Dawnchange Limited 100% · England and Wales

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 8 resigned

Name Role Appointed Born Nationality
AHMED, Farook Omar Director 2021-03-01 Mar 1978 British
DHALIWAL, Bhupinder Singh Director 2023-11-01 Aug 1977 British
SEHMI, Gurdev Singh Director 2015-03-01 Oct 1976 British
Show 8 resigned officers
Name Role Appointed Resigned
DHALIWAL, Bhupinder Singh Secretary 2003-04-14 2010-02-05
APEX COMPANY SERVICES LIMITED Corporate Nominee Secretary 2003-02-12 2003-02-14
AHMED, Farook Omar Director 2003-04-14 2020-04-01
DHALIWAL, Bhupinder Singh Director 2014-01-01 2022-12-24
DHALIWAL, Bhupinder Singh Director 2011-01-19 2013-06-01
DHALIWAL, Bhupinder Singh Director 2003-04-14 2010-02-05
SEHMI, Gurdev Singh Director 2003-04-14 2014-09-01
APEX NOMINEES LIMITED Corporate Nominee Director 2003-02-12 2003-02-14

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
X-Pharm Holdings Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2025-03-28 Active
Pharm Planet Holdings Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2024-12-17 Ceased 2025-03-28
Mr Farook Omar Ahmed Individual Voting 25–50% 2021-11-02 Ceased 2024-12-17
X-Pharm Investments Limited Corporate entity Shares 25–50% 2021-11-02 Ceased 2024-11-29
Mr Gurdev Singh Sehmi Individual Voting 25–50% 2016-04-06 Ceased 2024-12-17
Mr Bhupinder Singh Dhaliwal Individual Voting 25–50% 2016-04-06 Ceased 2024-12-17
Mr Farook Omar Ahmed Individual Shares 25–50%, Voting 25–50% 2016-04-06 Ceased 2020-04-01

Filing timeline

Last 20 of 148 total filings

Material constitutional events — rename, articles re-file, resolution

  • 2024-11-29 RESOLUTIONS Resolution
Date Type Category Description
2026-04-11 MR01 mortgage Mortgage create with deed with charles court order extend with charge number charge creation date
2026-03-17 CS01 confirmation-statement Confirmation statement with no updates PDF
2026-03-17 MR01 mortgage Mortgage create with deed with charge number charge creation date PDF
2025-12-31 AA accounts Accounts with accounts type full
2025-03-28 PSC02 persons-with-significant-control Notification of a person with significant control PDF
2025-03-28 PSC07 persons-with-significant-control Cessation of a person with significant control PDF
2025-02-24 MR01 mortgage Mortgage create with deed with charge number charge creation date PDF
2025-02-24 MR01 mortgage Mortgage create with deed with charge number charge creation date PDF
2025-02-21 CS01 confirmation-statement Confirmation statement with updates PDF
2025-02-13 PSC07 persons-with-significant-control Cessation of a person with significant control PDF
2025-01-05 AA accounts Accounts with accounts type full
2024-12-17 PSC02 persons-with-significant-control Notification of a person with significant control PDF
2024-12-17 PSC07 persons-with-significant-control Cessation of a person with significant control PDF
2024-12-17 PSC07 persons-with-significant-control Cessation of a person with significant control PDF
2024-12-17 PSC07 persons-with-significant-control Cessation of a person with significant control PDF
2024-12-05 SH02 capital Capital alter shares subdivision
2024-11-29 SH19 capital Capital statement capital company with date currency figure
2024-11-29 SH20 capital Legacy
2024-11-29 CAP-SS insolvency Legacy
2024-11-29 RESOLUTIONS resolution Resolution

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
4

last 12 months

Capital events
3

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page